208 related articles for article (PubMed ID: 33674442)
1. Qa-1
Zhang X; Sabio E; Krishna C; Ma X; Wang J; Jiang H; Havel JJ; Chan TA
Mol Cancer Res; 2021 Jun; 19(6):1076-1084. PubMed ID: 33674442
[TBL] [Abstract][Full Text] [Related]
2. The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects.
Oliveira CC; van Veelen PA; Querido B; de Ru A; Sluijter M; Laban S; Drijfhout JW; van der Burg SH; Offringa R; van Hall T
J Exp Med; 2010 Jan; 207(1):207-21. PubMed ID: 20038604
[TBL] [Abstract][Full Text] [Related]
3. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F
Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501
[TBL] [Abstract][Full Text] [Related]
4. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.
Kambayashi T; Kraft-Leavy JR; Dauner JG; Sullivan BA; Laur O; Jensen PE
J Immunol; 2004 Feb; 172(3):1661-9. PubMed ID: 14734748
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis.
Johnsen AK; Templeton DJ; Sy M; Harding CV
J Immunol; 1999 Oct; 163(8):4224-31. PubMed ID: 10510359
[TBL] [Abstract][Full Text] [Related]
6. Microenvironmental stresses induce HLA-E/Qa-1 surface expression and thereby reduce CD8(+) T-cell recognition of stressed cells.
Sasaki T; Kanaseki T; Shionoya Y; Tokita S; Miyamoto S; Saka E; Kochin V; Takasawa A; Hirohashi Y; Tamura Y; Miyazaki A; Torigoe T; Hiratsuka H; Sato N
Eur J Immunol; 2016 Apr; 46(4):929-40. PubMed ID: 26711740
[TBL] [Abstract][Full Text] [Related]
7. Remodeling of the tumor microenvironment via disrupting Blimp1
Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
[TBL] [Abstract][Full Text] [Related]
8. Peptide-receptive class I major histocompatibility complex molecules on TAP-deficient and wild-type cells and their roles in the processing of exogenous antigens.
Song R; Porgador A; Harding CV
Immunology; 1999 Jun; 97(2):316-24. PubMed ID: 10447748
[TBL] [Abstract][Full Text] [Related]
9. Imprint of Initial Education and Loss of Ly49C/I in Activated Natural Killer Cells of TAP1-KO and C57BL/6 Wildtype Mice.
Patil ND; Domingues O; Masquelier C; Theresine M; Schlienger O; Njinju Amin Asaba C; Thomas M; Seguin-Devaux C; Slevogt H; Ollert M; Zimmer J
Front Immunol; 2022; 13():818015. PubMed ID: 35911713
[TBL] [Abstract][Full Text] [Related]
10. Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19-IL2 cures poorly immunogenic tumors when combined with radiotherapy.
Olivo Pimentel V; Marcus D; van der Wiel AM; Lieuwes NG; Biemans R; Lieverse RI; Neri D; Theys J; Yaromina A; Dubois LJ; Lambin P
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33688020
[TBL] [Abstract][Full Text] [Related]
11. MHC Ib molecule Qa-1 presents Mycobacterium tuberculosis peptide antigens to CD8+ T cells and contributes to protection against infection.
Bian Y; Shang S; Siddiqui S; Zhao J; Joosten SA; Ottenhoff THM; Cantor H; Wang CR
PLoS Pathog; 2017 May; 13(5):e1006384. PubMed ID: 28475642
[TBL] [Abstract][Full Text] [Related]
12. Combination of NKG2A and PD-1 Blockade Improves Radiotherapy Response in Radioresistant Tumors.
Battaglia NG; Murphy JD; Uccello TP; Hughson A; Gavras NW; Caldon JJ; Gerber SA; Lord EM
J Immunol; 2022 Aug; 209(3):629-640. PubMed ID: 35840162
[TBL] [Abstract][Full Text] [Related]
13. Peptide-bound major histocompatibility complex class I molecules associate with tapasin before dissociation from transporter associated with antigen processing.
Li S; Paulsson KM; Sjögren HO; Wang P
J Biol Chem; 1999 Mar; 274(13):8649-54. PubMed ID: 10085102
[TBL] [Abstract][Full Text] [Related]
14. Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients.
Lazaridou MF; Gonschorek E; Massa C; Friedrich M; Handke D; Mueller A; Jasinski-Bergner S; Dummer R; Koelblinger P; Seliger B
Oncoimmunology; 2020 Jun; 9(1):1774323. PubMed ID: 32923135
[TBL] [Abstract][Full Text] [Related]
15. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
Chattopadhyay S; O'Rourke J; Cone RE
Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787
[TBL] [Abstract][Full Text] [Related]
16. Vectorized Treg-depleting αCTLA-4 elicits antigen cross-presentation and CD8
Semmrich M; Marchand JB; Fend L; Rehn M; Remy C; Holmkvist P; Silvestre N; Svensson C; Kleinpeter P; Deforges J; Junghus F; Cleary KL; Bodén M; Mårtensson L; Foloppe J; Teige I; Quéméneur E; Frendéus B
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35058324
[TBL] [Abstract][Full Text] [Related]
17. Identification of sequences in the human peptide transporter subunit TAP1 required for transporter associated with antigen processing (TAP) function.
Ritz U; Momburg F; Pircher HP; Strand D; Huber C; Seliger B
Int Immunol; 2001 Jan; 13(1):31-41. PubMed ID: 11133832
[TBL] [Abstract][Full Text] [Related]
18. T Cells Engaging the Conserved MHC Class Ib Molecule Qa-1
Doorduijn EM; Sluijter M; Querido BJ; Seidel UJE; Oliveira CC; van der Burg SH; van Hall T
Front Immunol; 2018; 9():60. PubMed ID: 29422902
[TBL] [Abstract][Full Text] [Related]
19. Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies.
Minnar CM; Chariou PL; Horn LA; Hicks KC; Palena C; Schlom J; Gameiro SR
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764364
[TBL] [Abstract][Full Text] [Related]
20. Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway.
Lu L; Ikizawa K; Hu D; Werneck MB; Wucherpfennig KW; Cantor H
Immunity; 2007 May; 26(5):593-604. PubMed ID: 17509909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
